PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
84 hedge funds and large institutions have $22.1M invested in PhenomeX Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 36 reducing their positions, and 32 closing their positions.
100% more call options, than puts
Call options by funds: $4K | Put options by funds: $2K
18% less funds holding
Funds holding: 102 → 84 (-18)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 36
56% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 32
65% less capital invested
Capital invested by funds: $63.3M → $22.1M (-$41.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Monaco Asset Management
Monaco
|
+$1.83M |
| 2 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
+$694K |
| 3 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$486K |
| 4 |
Renaissance Technologies
New York
|
+$224K |
| 5 |
Squarepoint
New York
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.91M |
| 2 |
BlackRock
New York
|
-$2.82M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.22M |
| 4 |
JP Morgan Chase
New York
|
-$922K |
| 5 |
State Street
Boston,
Massachusetts
|
-$861K |
CELL Hedge Fund Activity: Q2 2023 in Review
84 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q2 2023, worth a combined $22.1M — down 65% from $63.3M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of CELL and 14 opened new positions — a net loss of 18 holders — while 36 trimmed existing stakes and 16 added.
The largest buyer was Monaco Asset Management, adding an estimated $1.83M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.91M sold.
- 84 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q2 2023, down from 102 in Q1 2023.
- Funds reported $22.1M of PhenomeX Inc. Common Stock stock for Q2 2023, down 65% quarter-over-quarter.
- 14 funds opened new PhenomeX Inc. Common Stock positions in Q2 2023 and 32 closed out, a net change of -18 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q2 2023 was Monaco Asset Management, an estimated $1.83M added.
- The largest PhenomeX Inc. Common Stock seller in Q2 2023 was Perceptive Advisors, an estimated $2.91M sold.
Based on aggregated 13F filings for Q2 2023.